Literature DB >> 14730707

Glutamate transporter expression and function in human glial progenitors.

Nicholas J Maragakis1, Joerg Dietrich, Victor Wong, Haipeng Xue, Margot Mayer-Proschel, Mahendra S Rao, Jeffrey D Rothstein.   

Abstract

Glutamate is the major neurotransmitter of the brain, whose extracellular levels are tightly controlled by glutamate transporters. Five glutamate transporters in the human brain (EAAT1-5) are present on both astroglia and neurons. We characterize the profile of three different human astroglial progenitors in vitro: human glial restricted precursors (HGRP), human astrocyte precursors (HAPC), and early-differentiated astrocytes. EAAT 1, EAAT3, and EAAT4 are all expressed in GRPs with a subsequent upregulation of EAAT1 following differentiation of GRPs into GRP-derived astrocytes in the presence of bone morphogenic protein (BMP-4). This corresponds to a significant increase in the glutamate transport capacity of these cells. EAAT2, the transporter responsible for the bulk of glutamate transport in the adult brain, is not expressed as a full-length protein, nor does it appear to have functional significance (as determined by the EAAT2 inhibitor dihydrokainate) in these precursors. A splice variant of EAAT2, termed EAAT2b, does appear to be present in low levels, however. EAAT3 and EAAT4 expression is reduced as glial maturation progresses both in astrocyte precursors and early-differentiated astrocytes and is consistent with their role in adult tissues as primarily neuronal glutamate transporters. These human glial precursors offer several advantages as tools for understanding glial biology because they can be passaged extensively in the presence of mitogens, afford the potential to study the temporal changes in glutamate transporter expression in a tightly controlled fashion, and are cultured in the absence of neuronal coculture, allowing for the independent study of astroglial biology. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730707     DOI: 10.1002/glia.10310

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  34 in total

Review 1.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

Review 2.  Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury.

Authors:  Charles Nicaise; Dinko Mitrecic; Aditi Falnikar; Angelo C Lepore
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

Review 3.  Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia?

Authors:  Li-Nan Zhang; Liang Hao; Yu-Song Guo; Hai-Yan Wang; Lin-Lin Li; Li-Zhe Liu; Wen-Bin Li
Journal:  J Mol Med (Berl)       Date:  2019-01-23       Impact factor: 4.599

4.  δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes.

Authors:  Jianfeng Liang; Dongman Chao; Harleen K Sandhu; Yanbing Yu; Li Zhang; Gianfranco Balboni; Dong H Kim; Ying Xia
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

5.  Heterogeneity of Astrocytes in Grey and White Matter.

Authors:  Susanne Köhler; Ulrike Winkler; Johannes Hirrlinger
Journal:  Neurochem Res       Date:  2019-12-03       Impact factor: 3.996

6.  Caveolin-1 Sensitivity of Excitatory Amino Acid Transporters EAAT1, EAAT2, EAAT3, and EAAT4.

Authors:  Abeer Abousaab; Jamshed Warsi; Bernat Elvira; Florian Lang
Journal:  J Membr Biol       Date:  2015-12-21       Impact factor: 1.843

7.  Human glial progenitor engraftment and gene expression is independent of the ALS environment.

Authors:  Amanda M Haidet-Phillips; Arpitha Doreswamy; Sarah K Gross; Xiaopei Tang; James T Campanelli; Nicholas J Maragakis
Journal:  Exp Neurol       Date:  2014-12-16       Impact factor: 5.330

Review 8.  Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

Authors:  Keetae Kim; Seok-Geun Lee; Timothy P Kegelman; Zhao-Zhong Su; Swadesh K Das; Rupesh Dash; Santanu Dasgupta; Paola M Barral; Michael Hedvat; Paul Diaz; John C Reed; John L Stebbins; Maurizio Pellecchia; Devanand Sarkar; Paul B Fisher
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

9.  Regulation of glutamate transport in developing rat oligodendrocytes.

Authors:  Tara M DeSilva; Anatoli Y Kabakov; Patricia E Goldhoff; Joseph J Volpe; Paul A Rosenberg
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

10.  PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3.

Authors:  Olga Fedorenko; Cai Tang; Mentor Sopjani; Michael Föller; Eva-Maria Gehring; Nathalie Strutz-Seebohm; Oana N Ureche; Svetlana Ivanova; Arkadij Semke; Florian Lang; Guiscard Seebohm; Undine E Lang
Journal:  Psychopharmacology (Berl)       Date:  2009-07-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.